2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Adenoma: new trials by email Literature Review of Adenoma trials Research Report on Adenoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication Progel Sealant, Talcum Powder, Pain Questionnaire - Lung Diseases, Mesothelioma | Phase 3 | Withdrawn | M.D. Anderson Cancer Center | 2015-12-01 | 2015-12-15 | |
| A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) Eflornithine plus Sulindac, Eflornithine plus Placebo, Sulindac plus Placebo - Familial Adenomatous Polyposis | Phase 3 | Withdrawn | Cancer Prevention Pharmaceuticals, Inc. | 2011-03-01 | 2015-04-24 |
Adenomatous Polyposis Coli (1) · Colonic Polyps (1) · Lung Diseases (1) · Mesothelioma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenomatous Polyps (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genetic Diseases, Inborn (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1)
Eflornithine (1) · Sulindac (1) · Surveys and Questionnaires (1) · Talc (1)
Cancer Prevention Pharmaceuticals, Inc. (1) · M.D. Anderson Cancer Center (1)
Alfred M. Cohen, M.D. (1) · Reza J. Mehran, MD (1)